Lanx: Series A $25M

Lanx (Broomfield) a medical device company developing and marketing surgical implants and biological products for spinal surgery closed a $25M Series A financing led by Chicago Growth Partners and also included co-investors Goldman Sachs and Oakwood Medical Investors.

The Company currently markets 15 product lines of implants and associated instrumentation for spinal fusion surgery. Lanx is also aggressively developing additional product lines in its core fusion market as well as a broad platform of products in the emerging non-fusion and orthobiologics markets.

This is an incredibly exciting financing for Colorado, there are no Colorado institutional investors participating in this round, top-tier capital attraction came from Chicago, New York and St. Louis.

*NOTE* Feel the power of the Colorado BioScience Association (HERE)!
*NOTE* Take a look at the new Boulder Biotech Company Tree (HERE)!
*NOTE* Read the new eBook CLSDF 2007 - What's In A Year? (HERE)!

If you enjoyed this post get free email or RSS updates (here).